Class IITerminatedD-1240-2015
Drug recall · July 22, 2015
0.9% Sodium Chloride Injection USP recall
Why: Lack of assurance of sterility: Potential channel leaks near the threaded vial port.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68
- Lots / codes
Lot #: 49-084-JT; 49-119-JT
- Quantity
- 314600 bags
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- United States
- Initiated
- July 2, 2015 · Voluntary: Firm initiated
- Classified
- July 15, 2015
- Reported
- July 22, 2015
- Ended
- November 17, 2016
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.